顧みられない熱帯病治療の世界市場レポート2025年

顧みられない熱帯病治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.1％で45億2,000万米ドルに成長します。予測期間における主な成長促進要因としては、疾病モニタリングのためのデジタルツールの利用拡大、新薬やワクチンのパイプラインの増加、抗菌薬耐性に対する懸念の高まり、疾病管理のための国境を越えた協力体制の強化、気候変動が疾病の蔓延に及ぼす影響などが挙げられます。予測期間中に予想される注目すべき動向としては、局地的治療戦略の開発、手ごろな価格のワクチン・プラットフォーム、プライマリー・ヘルスケア・サービスとの統合、疾病サーベイランス・ネットワークの拡大、ベクター・コントロール技術の革新などが挙げられます。

感染症の流行の増加は、今後数年間の顧みられない熱帯病治療市場の成長を促進すると予想されます。感染症は、細菌、ウイルス、真菌、寄生虫などの有害な微生物によって引き起こされる病気で、人から人へ直接的または間接的に感染します。感染症の増加は、国境を越えた病原体の伝播を加速させる世界の渡航の増加が主な原因です。顧みられない熱帯病治療は、このような感染症の蔓延を抑制・撲滅するための標的療法を提供することで、重要な役割を果たしています。これらの治療は、特に脆弱な地域社会において有益であり、疾病負担を軽減し、長期的な障害を予防することによって、公衆衛生の成果を向上させる。例えば、2024年2月、英国健康安全保障局は、イングランドにおける結核患者が2023年には4,850人になり、2022年の4,380人から10.7％増加したと報告しました。この動向は、感染症の蔓延が顧みられない熱帯病治療への需要を促進していることを浮き彫りにしています。

顧みられない熱帯病治療市場の企業は、研究開発の強化、世界アクセスの拡大、革新的な治療法の開発のための戦略的投資を重視しています。こうした投資は、先進的な研究を支援し、共同研究を奨励し、十分な治療を受けていない人々のための安価で効果的な治療法の創出を促進することで、市場の成長に大きく貢献しています。例えば、2022年6月、スイスに本社を置く製薬会社ノバルティスAGは、顧みられない熱帯病（NTDs）とマラリア対策に2億5,000万米ドルを拠出しました。この資金援助は、低所得者層が治療を受けやすくし、これらの疾患に対する新しい治療法の開発を支援することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の顧みられない熱帯病治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の顧みられない熱帯病治療市場：成長率分析
• 世界の顧みられない熱帯病治療市場の実績：規模と成長, 2019-2024
• 世界の顧みられない熱帯病治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の顧みられない熱帯病治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の顧みられない熱帯病治療市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗寄生虫
• 抗真菌剤
• 抗生物質
• その他の薬物クラス
• 世界の顧みられない熱帯病治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リーシュマニア症
• 住血吸虫症
• リンパ系フィラリア症
• シャーガス病
• アフリカ睡眠病
• その他の病気の種類
• 世界の顧みられない熱帯病治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• 世界の顧みられない熱帯病治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の顧みられない熱帯病治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 在宅ケア設定
• その他のエンドユーザー
• 世界の顧みられない熱帯病治療市場抗寄生虫剤のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 駆虫薬
• 抗原虫
• 抗マラリア薬
• 外部寄生虫駆除剤
• 世界の顧みられない熱帯病治療市場抗真菌剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アゾール
• ポリエン
• アリルアミン
• エキノキャンディン
• 世界の顧みられない熱帯病治療市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• テトラサイクリン
• マクロライド
• リファマイシン
• スルホンアミド
• 世界の顧みられない熱帯病治療市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ウイルス薬
• コルチコステロイド
• 併用療法
• 支持療法

第7章 地域別・国別分析

• 世界の顧みられない熱帯病治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の顧みられない熱帯病治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 顧みられない熱帯病治療市場：競合情勢
• 顧みられない熱帯病治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi S.A.
• AstraZeneca PLC
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Astellas Pharma Inc.
• Eisai Co. Ltd.
• Shionogi And Co. Ltd.
• Dr. Reddy's Laboratories Ltd
• Cipla Ltd.
• Eiken Chemical Company Ltd
• LifeArc
• Atomwise Inc.
• Medicines Development for Global Health Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 顧みられない熱帯病治療市場2029：新たな機会を提供する国
• 顧みられない熱帯病治療市場2029：新たな機会を提供するセグメント
• 顧みられない熱帯病治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Neglected tropical disease (NTD) treatment refers to medical interventions aimed at controlling, eliminating, or eradicating a group of infectious diseases that predominantly impact impoverished populations in tropical and subtropical areas. The primary objective of these treatments is to reduce the disease burden, prevent disability, and enhance the quality of life within affected communities.

The primary drug classes utilized in treating neglected tropical diseases include anti-parasitic agents, antifungals, antibiotics, and others. Anti-parasitic agents are substances or treatments intended to prevent, kill, or eliminate parasites that infect humans, animals, or plants. These treatments address a range of diseases such as leishmaniasis, schistosomiasis, lymphatic filariasis, Chagas disease, African trypanosomiasis, and others. The drugs are administered either orally or parenterally and are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies. These treatments cater to multiple end users, such as hospitals, specialty clinics, homecare settings, and more.

The neglected tropical disease treatment market research report is one of a series of new reports from The Business Research Company that provides neglected tropical disease treatment market statistics, including the neglected tropical disease treatment industry's global market size, regional shares, competitors with the neglected tropical disease treatment market share, detailed neglected tropical disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the neglected tropical disease treatment market. This neglected tropical disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neglected tropical disease treatment market size has grown strongly in recent years. It will grow from $3.36 billion in 2024 to $3.57 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. This historical growth is attributed to a greater government focus on disease elimination programs, expanding public-private partnerships for drug donations, rising pharmaceutical donations from global manufacturers, increasing research into low-cost antiparasitic therapies, and growing investments in vaccine and diagnostic development.

The neglected tropical disease treatment market size is expected to see strong growth in the next few years. It will grow to $4.52 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. Key growth drivers in the forecast period include the expanded use of digital tools for disease monitoring, a growing pipeline of new drugs and vaccines, rising concerns about antimicrobial resistance, enhanced cross-border collaboration for disease control, and the influence of climate change on disease spread. Notable trends expected in the forecast period include the development of localized treatment strategies, affordable vaccine platforms, integration with primary healthcare services, expansion of disease surveillance networks, and innovations in vector control technologies.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the neglected tropical disease treatment market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread from one person to another either directly or indirectly. This rise in infectious diseases is primarily attributed to increased global travel, which accelerates the transmission of pathogens across borders. Neglected tropical disease treatment plays a crucial role by offering targeted therapies that help control and eliminate the spread of these diseases. These treatments are particularly beneficial in vulnerable communities, where they improve public health outcomes by reducing disease burden and preventing long-term disabilities. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased to 4,850 in 2023, a 10.7% rise from 4,380 cases in 2022. This trend highlights how the growing prevalence of infectious diseases is fueling the demand for neglected tropical disease treatments.

Companies in the neglected tropical disease treatment market are emphasizing strategic investments to strengthen research and development, broaden global access, and advance innovative therapies. These investments contribute significantly to market growth by supporting advanced research, encouraging collaborations, and expediting the creation of affordable and effective treatments for underserved populations. For instance, in June 2022, Novartis AG, a pharmaceutical corporation based in Switzerland, committed $250 million toward combating neglected tropical diseases (NTDs) and malaria. This funding aims to make treatments more accessible in low-income regions and to support the development of new therapies for these diseases.

In August 2022, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, and Aurigene Pharmaceutical Services Limited, also based in India, collaborated with the Drugs for Neglected Diseases initiative (DNDi) to develop, manufacture, and commercialize new treatments for neglected tropical diseases. This partnership is intended to speed up the development of affordable and accessible therapies, addressing the unmet medical needs in low- and middle-income countries. The DNDi, headquartered in Switzerland, is a non-profit organization dedicated to developing effective and affordable treatments for neglected tropical diseases.

Major players in the neglected tropical disease treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Eisai Co. Ltd., Shionogi And Co. Ltd., Dr. Reddy's Laboratories Ltd, Cipla Ltd., Eiken Chemical Company Ltd, LifeArc, Atomwise Inc., and Medicines Development for Global Health Ltd.

Asia Pacific was the largest region in the neglected tropical disease treatment market in 2024. The regions covered in neglected tropical disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neglected tropical disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neglected tropical disease treatment market consists of revenues earned by entities by providing services such as mass drug administration, disease surveillance, diagnostic testing, patient care and management, health education, and vector control programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The neglected tropical disease (NTD) treatment market also includes sales of diagnostic kits, vaccines, insecticides, and medical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neglected Tropical Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neglected tropical disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neglected tropical disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neglected tropical disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Anti-Parasite; Antifungal; Antibiotics; Other Drugs Class
• 2) By Disease Type: Leishmaniasis; Schistosomiasis; Lymphatic Filariasis; Chagas Disease; African Trypanosomiasis; Other Disease Types
• 3) By Route of Administration: Oral; Parenteral
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 5) By End User: Hospital; Specialty Clinics; Homecare Settings; Other End Users
• Subsegments:
• 1) By Anti-Parasite: Anthelmintics; Antiprotozoals; Antimalarials; Ectoparasiticides
• 2) By Antifungal: Azoles; Polyenes; Allylamines; Echinocandins
• 3) By Antibiotics: Tetracyclines; Macrolides; Rifamycins; Sulfonamides
• 4) By Other Drug Classes: Antivirals; Corticosteroids; Combination Therapies; Supportive Treatments
• Companies Mentioned: Pfizer Inc.; Johnson And Johnson; Merck And Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neglected Tropical Disease Treatment Market Characteristics

3. Neglected Tropical Disease Treatment Market Trends And Strategies

4. Neglected Tropical Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neglected Tropical Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neglected Tropical Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neglected Tropical Disease Treatment Market Growth Rate Analysis
• 5.4. Global Neglected Tropical Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neglected Tropical Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neglected Tropical Disease Treatment Total Addressable Market (TAM)

6. Neglected Tropical Disease Treatment Market Segmentation

• 6.1. Global Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Parasite
• Antifungal
• Antibiotics
• Other Drugs Class
• 6.2. Global Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leishmaniasis
• Schistosomiasis
• Lymphatic Filariasis
• Chagas Disease
• African Trypanosomiasis
• Other Disease Types
• 6.3. Global Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• 6.4. Global Neglected Tropical Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.5. Global Neglected Tropical Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Specialty Clinics
• Homecare Settings
• Other End Users
• 6.6. Global Neglected Tropical Disease Treatment Market, Sub-Segmentation Of Anti-Parasite, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anthelmintics
• Antiprotozoals
• Antimalarials
• Ectoparasiticides
• 6.7. Global Neglected Tropical Disease Treatment Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Azoles
• Polyenes
• Allylamines
• Echinocandins
• 6.8. Global Neglected Tropical Disease Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetracyclines
• Macrolides
• Rifamycins
• Sulfonamides
• 6.9. Global Neglected Tropical Disease Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antivirals
• Corticosteroids
• Combination Therapies
• Supportive Treatments

7. Neglected Tropical Disease Treatment Market Regional And Country Analysis

• 7.1. Global Neglected Tropical Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neglected Tropical Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neglected Tropical Disease Treatment Market

• 8.1. Asia-Pacific Neglected Tropical Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neglected Tropical Disease Treatment Market

• 9.1. China Neglected Tropical Disease Treatment Market Overview
• 9.2. China Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neglected Tropical Disease Treatment Market

• 10.1. India Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neglected Tropical Disease Treatment Market

• 11.1. Japan Neglected Tropical Disease Treatment Market Overview
• 11.2. Japan Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neglected Tropical Disease Treatment Market

• 12.1. Australia Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neglected Tropical Disease Treatment Market

• 13.1. Indonesia Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neglected Tropical Disease Treatment Market

• 14.1. South Korea Neglected Tropical Disease Treatment Market Overview
• 14.2. South Korea Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neglected Tropical Disease Treatment Market

• 15.1. Western Europe Neglected Tropical Disease Treatment Market Overview
• 15.2. Western Europe Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neglected Tropical Disease Treatment Market

• 16.1. UK Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neglected Tropical Disease Treatment Market

• 17.1. Germany Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neglected Tropical Disease Treatment Market

• 18.1. France Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neglected Tropical Disease Treatment Market

• 19.1. Italy Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neglected Tropical Disease Treatment Market

• 20.1. Spain Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neglected Tropical Disease Treatment Market

• 21.1. Eastern Europe Neglected Tropical Disease Treatment Market Overview
• 21.2. Eastern Europe Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neglected Tropical Disease Treatment Market

• 22.1. Russia Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neglected Tropical Disease Treatment Market

• 23.1. North America Neglected Tropical Disease Treatment Market Overview
• 23.2. North America Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neglected Tropical Disease Treatment Market

• 24.1. USA Neglected Tropical Disease Treatment Market Overview
• 24.2. USA Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neglected Tropical Disease Treatment Market

• 25.1. Canada Neglected Tropical Disease Treatment Market Overview
• 25.2. Canada Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neglected Tropical Disease Treatment Market

• 26.1. South America Neglected Tropical Disease Treatment Market Overview
• 26.2. South America Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neglected Tropical Disease Treatment Market

• 27.1. Brazil Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neglected Tropical Disease Treatment Market

• 28.1. Middle East Neglected Tropical Disease Treatment Market Overview
• 28.2. Middle East Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neglected Tropical Disease Treatment Market

• 29.1. Africa Neglected Tropical Disease Treatment Market Overview
• 29.2. Africa Neglected Tropical Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neglected Tropical Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neglected Tropical Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neglected Tropical Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Neglected Tropical Disease Treatment Market Competitive Landscape
• 30.2. Neglected Tropical Disease Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Neglected Tropical Disease Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. AstraZeneca PLC
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Astellas Pharma Inc.
• 31.8. Eisai Co. Ltd.
• 31.9. Shionogi And Co. Ltd.
• 31.10. Dr. Reddy's Laboratories Ltd
• 31.11. Cipla Ltd.
• 31.12. Eiken Chemical Company Ltd
• 31.13. LifeArc
• 31.14. Atomwise Inc.
• 31.15. Medicines Development for Global Health Ltd.

32. Global Neglected Tropical Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neglected Tropical Disease Treatment Market

34. Recent Developments In The Neglected Tropical Disease Treatment Market

35. Neglected Tropical Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Neglected Tropical Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neglected Tropical Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neglected Tropical Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer